» Articles » PMID: 34831406

Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases

Overview
Journal Cells
Publisher MDPI
Date 2021 Nov 27
PMID 34831406
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The blood-brain barrier (BBB) is a vital structure for maintaining homeostasis between the blood and the brain in the central nervous system (CNS). Biomolecule exchange, ion balance, nutrition delivery, and toxic molecule prevention rely on the normal function of the BBB. The dysfunction and the dysregulation of the BBB leads to the progression of neurological disorders and neurodegeneration. Therefore, in vitro BBB models can facilitate the investigation for proper therapies. As the demand increases, it is urgent to develop a more efficient and more physiologically relevant BBB model. In this review, the development of the microfluidics platform for the applications in neuroscience is summarized. This article focuses on the characterizations of in vitro BBB models derived from human stem cells and discusses the development of various types of in vitro models. The microfluidics-based system and BBB-on-chip models should provide a better platform for high-throughput drug-screening and targeted delivery.

Citing Articles

Biomaterials for neuroengineering: applications and challenges.

Wu H, Feng E, Yin H, Zhang Y, Chen G, Zhu B Regen Biomater. 2025; 12:rbae137.

PMID: 40007617 PMC: 11855295. DOI: 10.1093/rb/rbae137.


Recent Developments in Glioblastoma-On-A-Chip for Advanced Drug Screening Applications.

Maity S, Bhuyan T, Jewell C, Kawakita S, Sharma S, Nguyen H Small. 2024; 21(1):e2405511.

PMID: 39535474 PMC: 11719323. DOI: 10.1002/smll.202405511.


Viscoelasticity of Hyaluronic Acid Hydrogels Regulates Human Pluripotent Stem Cell-derived Spinal Cord Organoid Patterning and Vascularization.

Chen X, Liu C, McDaniel G, Zeng O, Ali J, Zhou Y Adv Healthc Mater. 2024; 13(32):e2402199.

PMID: 39300854 PMC: 11671291. DOI: 10.1002/adhm.202402199.


Unraveling the complexity of human brain: Structure, function in healthy and disease states.

Sultana O, Bandaru M, Islam M, Reddy P Ageing Res Rev. 2024; 100:102414.

PMID: 39002647 PMC: 11384519. DOI: 10.1016/j.arr.2024.102414.


Revolutionizing neurotherapeutics: blood-brain barrier-on-a-chip technologies for precise drug delivery.

Kantawala B, Shariff S, Ramadan N, Fawaz V, Hassan Y, Mugisha N Ann Med Surg (Lond). 2024; 86(5):2794-2804.

PMID: 38694300 PMC: 11060226. DOI: 10.1097/MS9.0000000000001887.


References
1.
Pardridge W . Blood-brain barrier delivery. Drug Discov Today. 2007; 12(1-2):54-61. DOI: 10.1016/j.drudis.2006.10.013. View

2.
Blanchard J, Bula M, Davila-Velderrain J, Akay L, Zhu L, Frank A . Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020; 26(6):952-963. PMC: 7704032. DOI: 10.1038/s41591-020-0886-4. View

3.
Pandey P, Sharma A, Gupta U . Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking. Tissue Barriers. 2016; 4(1):e1129476. PMC: 4836458. DOI: 10.1080/21688370.2015.1129476. View

4.
Yao Y, Chen Z, Norris E, Strickland S . Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun. 2014; 5:3413. PMC: 3992931. DOI: 10.1038/ncomms4413. View

5.
de Jong E, Williams D, Abdelmohsen L, van Hest J, Zuhorn I . A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy. J Control Release. 2018; 289:14-22. DOI: 10.1016/j.jconrel.2018.09.015. View